Journal of Cancer Research and Therapeutics

ORIGINAL ARTICLE
Year
: 2022  |  Volume : 18  |  Issue : 2  |  Page : 488--495

Golgi phosphoprotein 3 promotes ovarian cancer progression and is associated with cisplatin resistance


Teng Liu1, Zhen-Wei Jin2, Ying Li1, Ge Zhang1, Xiao-Ying Yang3, Xiao-Meng Xu1, Ying-Chun Ma2 
1 Department of Obstetrics and Gynecology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Key Laboratory of Laparoscopic Technology, The First Affiliated Hospital of Shandong First Medical University; Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong, P.R. China
2 Department of Obstetrics and Gynecology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Key Laboratory of Laparoscopic Technology, The First Affiliated Hospital of Shandong First Medical University, Jinan, Shandong, P.R. China
3 Department of Obstetrics and Gynecology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Key Laboratory of Laparoscopic Technology, The First Affiliated Hospital of Shandong First Medical University, Jinan, Shandong; Weifang Medical University, Clinical medical college, Weifang, Shandong, P.R. China

Correspondence Address:
Ying-Chun Ma
Department of Obstetrics and Gynecology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Key Laboratory of Laparoscopic Technology, The First Affiliated Hospital of Shandong First Medical University, No. 16766 Jingshi Road, Jinan, Shandong
P.R. China

Background: Golgi phosphoprotein-3 (GOLPH 3) is involved in the development of several human cancers. However, the clinical significance and biological role of GOLPH 3 in ovarian cancer (OC) remains unknown. Methods: The expression of GOLPH 3 in OC cell lines was quantified using real-time quantitative polymerase chain reaction (RT-qPCR) and western blot assays. The role of GOLPH 3 in tumorigenicity, migration, and invasion of OC cell lines by small interference RNA, scratch wound-healing assays, and transwell assays was detected. In addition, western blotting was used to determine whether GOLPH 3 is associated with the PI3K/AKT/mTOR signaling pathway. Furthermore, RT-qPCR verified whether GOLPH 3 is associated with drug resistance. Results: GOLPH 3-positive expression rate was higher in OC. Downregulation of GOLPH 3 markedly inhibited the migration and invasion and may be related to the PI3K/AKT/mTOR signal pathway. Moreover, the result of the experiment proved that GOLPH 3 enhances the sensitivity of OC to cisplatin by regulating ATP7A/B. GOLPH 3 promoted the invasion and migration of OC, and the mechanism may be related to the PI3K/Akt/mTOR pathway. In addition, inhibition of GOLPH 3 increased the sensitivity of OC cells to cisplatin, which may be associated with ATP7A/B. Conclusion: This study found that GOLPH3 may promote the migration and invasion of OC cells through PI3K/Akt/mTOR pathway. At the same time, low expression of GOLPH3 increased the sensitivity of OC cells to cisplatin.


How to cite this article:
Liu T, Jin ZW, Li Y, Zhang G, Yang XY, Xu XM, Ma YC. Golgi phosphoprotein 3 promotes ovarian cancer progression and is associated with cisplatin resistance.J Can Res Ther 2022;18:488-495


How to cite this URL:
Liu T, Jin ZW, Li Y, Zhang G, Yang XY, Xu XM, Ma YC. Golgi phosphoprotein 3 promotes ovarian cancer progression and is associated with cisplatin resistance. J Can Res Ther [serial online] 2022 [cited 2022 Aug 16 ];18:488-495
Available from: https://www.cancerjournal.net/article.asp?issn=0973-1482;year=2022;volume=18;issue=2;spage=488;epage=495;aulast=Liu;type=0